Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse

Tatiana N Sharapova1, Elena A Romanova1, Aleksandr S Chernov2

  • 1Laboratory of Molecular Immunogenetics of Cancer, Institute of Gene Biology RAS, Vavilova 34/5, 111394 Moscow, Russia.

Insights

New peptides from the Tag7 protein can inhibit key receptors involved in severe inflammation, potentially offering a novel therapy for acute lung injury and COVID-19 complications.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infections can trigger a
  • cytokine storm
  • leading to severe coronavirus disease 2019 (COVID-19) and high mortality.
  • This excessive inflammation is linked to overactive receptors like TREM-1 and TNFR1.
  • Innate immunity protein Tag7 plays a role in regulating immune responses.

Purpose of the Study:

  • To investigate the potential of Tag7-derived peptides in modulating inflammatory responses.
  • To determine if these peptides can inhibit TREM-1 and TNFR1 activation.
  • To evaluate the therapeutic potential of Tag7 peptides in acute lung injury (ALI) models.

Main Methods:

  • Peptide synthesis from N-terminal and C-terminal fragments of Tag7.
  • Assays using peripheral blood mononuclear cells (PBMCs) from healthy donors.
  • In vivo studies using a mouse model of acute lung injury (ALI) with diffuse alveolar damage (DAD).

Main Results:

  • Tag7-derived peptides selectively inhibit TREM-1 (N-terminal) and TNFR1 (C-terminal) receptors.
  • Peptides reduced proinflammatory cytokine production in PBMCs and in the ALI mouse model.
  • Treatment decreased mononuclear cell infiltration into the lungs of DAD model animals.

Conclusions:

  • Tag7-derived peptides demonstrate potent anti-inflammatory properties by targeting TREM-1 and TNFR1.
  • These peptides show promise for preventing or treating acute lung injury, including severe pulmonary manifestations of COVID-19.
  • Further research into Tag7 peptides could lead to novel therapeutic strategies for inflammatory lung diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
11.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K